N
XENT

Natixis’s Intersect ENT, Inc XENT Stock Holding History

Natixis’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-244,600
Closed -$6.85M – 1445
2022
Q1 		$6.85M Sell
244,600
-121,600
-33% -$3.33M 0.02% 474
2021
Q4 		$10M Buy
+366,200
New +$9.92M 0.03% 398

Natixis's XENT Position: Q2 2022 in Review

Natixis sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 244,600 shares — an estimated $6.85M sold.

Natixis first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $10M in Q4 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Natixis reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Natixis sold 244,600 Intersect ENT, Inc shares in Q2 2022, an estimated $6.85M.
  • Natixis first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
  • Natixis's Intersect ENT, Inc position peaked at $10M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Natixis's 13F filing for Q2 2022, filed 12 Aug 2022.